has been linked to an impaired dilator function of the coronary mlcrovascular endothehum m vwo However, the profile and mechanism of this dysfunction remam obscure Thus, this study compared diameter responses to acetylchohne (ACH), bradykmm (BKN), and substance P (SP) between coronary nucrovessels (1 d =106?4 pm) dissected from left ventricles of normotenslve and hypertensive Dahl rats (Dahl-NT and Dahl-HT, respectively) Vessels were cannulated and pressurized on glass pipettes at 80 mm Hg, and Internal diameters were monitored by vldeomlcroscopy Coronary mlcrovessels from Dahl-NT and Dahl-HT showed similar dilator responses to ACH (100 pmol/L to 10 pmol/L), with maximal diameter increases of 6325 pm and 63+7 pm, respectively (n=31,17) However, only vessels from Dahl-NT showed dilator responses to SP (10 fmol/L to 1 nmol/L) and BKN (100 fmol/L to 10 nmol/L) All dilator responses persisted after N-mtro-L-argmme (10 Fmol/L) or mdomethacm (10 pmol/L), but were blunted after mhlbltton of cytochrome P450 by 10 pmol/L octadecynolc acid (n=6-8)
H ypertenslon IS associated with increased cardiovascular morbldlty and mortality, even when large eplcardlal coronary artenes are anglographlcaliy normal 'M Hence, coronary vascular dysfunction IS proposed to reside at the mlcroclrculatory level m some forms of hypertension 'M In this regard, Egashlra et al5 reported that epicardial coronary arteries from normotemlve and hypertensive patients showed similar dllatlons during mtracoronary infusion of substance P, a potent endothehum-dependent dilator peptlde However, substance P-induced increases m coronary blood flow were blunted fourfold m the hypertensive subjects, lmphcatmg the small coronary resistance vessels as the site of endothehal dilator dysfunction Additionally, Antony et al" observed that hypertensive patients with anglographlcally normal coronary arteries rhowed a blunting of endothehum-dependent, flow-mediated dllatlon, which impaired the coronary blood flow response to increased myocardlal demand This failure of the mlcrovascular endothehum to provide adequate dilation of the coronary mlcrocn-culatlon has been postulated to facilitate myocardlal lschemla m patients with hypertension '-' Surpnsmgly, although rat models often are used to identify the mechanisms of hypertension-related vascular pathologies, the effect of hypertension on endothehal dilator function has not been studied m rat coronary mlcrovessels Furthermore, little IS known about the relative roles of mtrlc oxide, cyciooxygenase products, or cytochrome P450 products m mediating the endothehumdependent responses of these regulatory vessels Thus the goals of this study were (1) to compare endothehum-mediated dilator responses to acetylcholme, substance P, and bradykmm between isolated coronary mlcrovessels from normotenslve and hypertensive salt-sensitive Dahl rats and (2) to begm to define the endothehal-denved factors which mediate the vasoactlve responses induced by these same substances m Isolated coronary mlcrovessels from the Dahl rat model
Methods

Experimental
Animal Model
Male Dahl salt-sensltlve rats were obtamed from either Harlan Sprague Dawley, Inc (Indlanapohs, Indiana), or from an inbred colony at the Medlcal College of Wlsconsm, which has been mamtamed by brother-sister matmg smce 1991 All rats were fed a 0 4% NaCl (low-salt) diet from weanmg until 8 weeks of age At this tune, htter mates either contmued on a 0 4% NaCl (low-salt) diet, or were placed on an 8% NaCl (high-salt) diet All rats had free access to dnnkmg water At 9 5 to 10 weeks of age, the ammals were weighed, thehum-derived P450 metabohte as a dilator mediator, we alternatively examined if the blunting of these dllatlons by ODYA might instead represent a nonspecific mhlbltlon of vascular smooth muscle relaxation However, ODYA (10 pmol/L) did not blunt the progressive dilator response of mlcrovessels to the Ca2+ channel blocker, mfedlpme (10 pmol/L to 1 pmol/L, half-log units), which induced halfmaximal dilation at concentrations of 7?2 nmol/L and 6tl nmol/L and maximally dilated arteries by 5528 pm and 69?7 pm m the absence and presence of 10 PM ODYA, respectively (n=3) Furthermore, appropriate addltlons of the ethanol solvent for ODYA did not attenuate relaxations to ACH, SP or BKN m coronary mlcrovessels of Dahl-NT rats (n=2-3)
Fig 5B shows that L-NNA (10 pmol/L) also did not mhlblt the progressive dilator response to ACH m mlcrovessels from Dahl-HT rats, or alter the impaired diameter responses to SP and BKN m these vessels In contrast, ODYA (10 pmol/L) depressed the concentration-response curve to ACH and inhibited the maximal diameter increase by 35?21% (n=6) The impaired dilator response to SP m coronary mlcrovessels from Dahl-HT rats was not affected by ODYA, whereas this blocking drug unmasked a constrictor response to higher concentrations of BKN (n=6) Figure  6 . Because constrictor products of the cyclooxygenase pathway may blunt endothehum-dependent dilations m systemic arteries, 's-'s we further examined if cyclooxygenase-denved products were mvolved m modulatmg the vasoactlve responses observed m this study However, Fig 6A shows 
Discussion
This 1s one of the first studies to examine endothehal dilator function m isolated coronary mlcrovessels from a rat model of hypertension, and several new findings have emerged First, It appears that coronary mlcrovessels from Dahl-HT rats show a unique pattern of endothehal impairment compared to large systemic vessels In particular, the blunted dilator response to ACH observed m systemic artenes of hypertensive animals and humans'5-'" was not observed m this study of coronary mlcrovessels from Dahl-HT rats Second, we found little evldence that the Impaired dilator responses to SP and BKN m coronary mlcrovessels from Dahl-HT rats were related to the release of a cyclooxygenase-derived constrictor factor, although this mechanism has been proposed to contribute to endothehal dilator defects m systemic arteries "W Finally, our findings implicate a cytochrome P450 product, rather than mtnc oxide, as an important mediator of the dilator responses to ACH, SP, and BKN m coronary mlcrovessels from the Dahl rat strain A Distinct Pattern of Endothelial Dilator Dysfunction in CRA from Dahl-HT Rats
Our study has uncovered mltlal evidence of a distinct pattern of endothehal dysfunction m coronary mlcrovessels exposed to short-term hypertension m Dahl rats In these rat intramural coronary arteries, which possess a high level of myogemc tone and may assist m regulating coronary blood flow,'" normal dilator responses to ACH persisted at a time when the dilator responses to the native coronary peptldes, SP and BKN, were markedly blunted This profile 1s dlstmctly different from the pattern of endothehal dysfunction observed m the aorta, cerebral, and renal artenes of several rat models of hypertenclan, including the aorta of Dahl salt-sensitive rats, m which a blunted dilator response to ACH has been the hallmark finding 2'm23 It further differs from the observations that the dilator response to ACH 1s blunted m the forearms of humans with essential, renovascular, and aldosterone-induced forms of hypertension '* " " 24 However, our findings may relate to earlier reports that ACH-induced, mtnc-oxide mediated dllations persist in rings of main coronary artenes from spontaneously hypertensive rats, and that they also persist m mam coronary arteries from the same rat strain cannulated for vessel perfusion 25 2h Furthermore, a dlrmmshed dilator response to BKN concurrent with intact ACH-induced dilations also has been observed m the mesentenc vasculature of genetically hypertensive rats and m the cutaneous clrculatlon of the forearms of humans with essential hypertension " 28 Hence, to date, it appears that the sparing of ACH-induced dilation during hypertension may be a novel feature of several vascular beds Interestingly, a normal dilator response to ACH also has been reported m coronary arteries of humans with essential hypertenslon,3 although this finding has not been consistent between all mvestlgators 4 '
In contrast, the finding of Impaired dilator responses to SP and BKN m our coronary mlcrovessels concurs with observations of recent clmlcal studies, which have demonstrated that SP-induced dilations are blunted m the coronary mlcroclrculatlon of human subjects with essential hypertension 5 Hence, our report of a slmllar abnormality m a coronary mlcrovessel preparation may prove helpful m provldmg an m vitro model m which to obtain mechamstlc mformatlon on the nature of this abnormality Notably, our data show that SP and BKN potently dilate isolated rat coronary mlcrovessels, and, slmllarly, mtracoronary mfuslon of these peptldes increases coronary blood flow m vlvo is20 However, m isolated rings of large coronary arteries from some species, including the rat, SP shows little vasoactlve effect, whereas BKN ehclts vascular contraction " The different vasoactlve effects of SP and BKN on large versus small coronary arteries suggest that the m vitro study of vascular pathologies related to these peptldes may be best characterized m mlcrovessel preparations What is the Site of Endothelial Dilator Dysfunction in Coronary Microvessels?
It 1s unclear which pathophyslologlcal processes would perrmt, m the same coronary mlcrovessel, the perslstance of an intact ACH-induced dilation at a time when SP and BKN-induced dilations are impaired by the hypertensive disease Our findIng that ODYA, an inhibitor of the cytochrome P450 pathway, blunted the dilator responses to ACH, SP and BKN m coronary mlcrovessels of Dahl-NT rats to a snmlar extent, lmplles that all three of these substances may exert at least part of their dilator action through this common pathway Furthermore, it appears that this pathway 1s still intact m coronary mlcrovessels from Dahl-HT rats, because these vessels, which demonstrated full dilator responses to ACH, also were sensitive to block by ODYA Hence, the defective site m the endotheha1 cell associated with impaired SP and BKN-induced dilation appears to be located proximal to mediator release, and, apparently, it 1s related to membrane or intracellular events specific to the processmg of the SP and BKN receptor signal
In this respect, activation of BKN and SP receptor-linked G proteins has been identified as a cntlcal step m endothehal cell signaling, which results m phophohpase activation and release of endothehal cytochrome P450 dilator products Specific G proteins, msensltlve to pertussls toxin, may be coupled to peptlde receptors, whereas other G protein molecules may transduce receptor signals from other dilator agonists 30,3' Modulation of G protein function m endothehal cells 1s postulated to occur m atherosclerotic disease and also may occur durmg the endothehal remodeling, which occurs after balloon cathetenzatlon, suggestmg that these proteins are readily modulated by cardiovascular pathologes 3"32 Thus, a further defimtlon of the events, which signal the release of dilator factors from the endothehum, may help pmpomt the molecular sites of dysfunction m the endothehal cells during hypertension and may provide clues to enable the prevention or reversal of coronary endothehal abnormahtles No Evidence for an Endothelium-Derived Constvictov Factor in Covonay Micvovessels.
In the aorta and m the renal and cerebral artenes of the SHR, the blunted dilator response to acetylcholme 1s due to the production of a cyclooxygenase-denved constrictor factor, which may be prostaglandm H2 (PGH,) '5-'8~33 In these vessels, pharmacolog& block of cyclooxygenase by mdomethacm restores ACH-induced dilator responses, and mdomethacm also nnproves endothehum-mediated dilation m the human forearm '5-'x24~33 However, m our study, mdomethacm had no slgmficant effect on the dilator responses to ACH, SP, and BKN m coronary mlcrovessels from Dahl-NT rats, and it also did not alter the dilator response to ACH, which persisted m the vessels from the Dahl-HT rat Furthermore, cyclooxgenase mhlbltlon also did not restore the dilator responses to SP and BKN to the coronary mlcrovessels of the Dahl-HT rat Hence, our results provide little direct evidence that the release of a cyclooxygenase-denved constrictor factor from the coronary endothehum contributes to the blunting of SP-and BKNinduced dilation m coronary mlcrovessels from hypertensive Dahl rats However, the posslblllty remains that the mhlbltlon by mdomethacm of the cyclooxygenase pathway for arachldome acid metabolism may have shunted arachldomc acid to alternative metabolic pathways, thereby enhancing the synthe-SIS of other constrictor factors and preventing the restoration of full dilator responses to SP and BKN durmg cyclooxygenase block A Cytochvome P450 Product May Mediate Endothelium-Dependent Dilations
Several dilator factors are released by the coronary endothehurn, including nitric oxide, prostacychn, and at least one cytochrome P450 product postulated to be a hyperpolarlzmg factor "' 34 35 Of these substances, pharmacological qtudles have lmphcated nitric oxide as the primary mediator of endothehurn-dependent dllatlons to ACH and BKN m large porcine and bovine coronary arteries, although products of the cytochrome P450 pathway also may contribute to dilator responses 34V35 Slmllarly, nitric oxide also has been implicated as the primary endothehum-derived mediator of dilation m large rat coronary arteries, where it appears to fully account for the relaxation response to ACH m strain gauge recordings's In contrast, results from this study m rat coronary mlcrovessels, which were studied by similar pharmacological approaches, found no evidence for mtnc oxide as a mediator of the dilator responses to ACH, SP or BKN Rather, our results suggest that a product of the cytochrome P450 pathway mediates m part the dilator responses to these substances, with a residual dilator component resistant to drug block Although the endothehum-derived P450 products which mediate dllatlon of isolated coronary mlcrovessels have not been defined, an epoxygenase dilator product, with properties of a potasqmm channel opener and hence, a hyperpolarlzmg substance, has been described m large coronary arteries 36 Our results provide mltlal evidence for the role of a similar product m mediating endothehum-dependent dllatlons m the rat coronary microcn-culatlon, and emphasize the potential importance of the P450 pathway m the regulation of coronary mlcrovascular tone However, the existence of multiple interacting vasodllator pathways m these vessels should not be excluded, partlcularly m view of the finding that ODYA did not completely abohrh the agonist-induced dilations induced by ACH, SP and BKN m coronary mlcrovessels of Dahl-NT rats
Limitations of the Study
Several aspects of our study should be acknowledged as possible hmltatlons First, our vessels were obtained from salt-sensitive Dahl rats, some of which were fed a high-salt diet to induce a short-term, volume-expanded form of hypertenslon 37 Notably, this model permits the comparison of endothehal function between normotenslve and hypertensive ammals with the same genotype
The short duration of hypertension also mmlmlzes vascular structural changes Although some degree of vascular remodeling cannot be dlscounted m this study, the similar passive diameter values we observed between mlcrovessels from Dahl-NT and Dahl-HT rats provided no overt evidence for structural changes However, the genetic, pressure, and endocrine profiles of the Dahl rat may not resemble other rat models of hypertension," and, hence, the functional profile of the endothehal cells also may not be readily comparable Second, our Dahl rats were fed a high-salt diet to produce a volume-expanded model of high blood pressure, and, hence, salt-feeding per se may have influenced endothehal funcnon m our study Studies performed by Luscher et al on aortas of salt-reslstant Dahl rate mdlcated httle effect of a high-salt diet on endothehum-dependent dilations, mcludmg those to ACH ** However, recent work by Lm et al" suggests that isolated skeletal mlcrovessels, obtained from normotenslve rats fed a 4% NaCl diet for 4 to 8 weeks, show attenuated endothehum-dependent dilator responses to ACH and the prostacychn analogue lloprost Studies by Boegehold"" further tuggest an attenuation of endothehum-dependent, flow-medlated dilation m the rat skeletal muscle mlcroclrculatlon m VIVO, after feedmg of a 7% NaCl diet to normotenslve rats for 2 weeks Hence, an effect of salt-feeding on the endothehunidependent dilator responses of this study cannot be dlscounted, and additional studies exammmg endothehal function m coronary mlcroves\els from other rat models of hypertension are warranted
Possible Physiological
Relevance of the Findings
The physlologlcal relevance ofour findings rely on a functional role for ACH, SP, and BKN m the coronary clrculatlon m vlvo In this respect, ACH represents a chohnergc neurotransmltter, which 1s localized m parasympathetic nerve endings at the outer medlal layer of small coronary arteries 4' Its release by vagal nerve activity 1s asqoclated with stunulatlon of muscarmlc receptors on coronary endothehal cells, and with coronary vasodllatlon 42 The chmcal role of parasympathetic, neurallymedlated coronary dilation 1s untested, but it 1s postulated to reinforce the metabolic regulation of coronary blood flow " Hence, the penlstence of ACH-induced dilator responses m coronary mlcrovessels durmg hypertension may act to extend continued protcbctlon to some regions of the myocardlum In contrast, recent attention has focused on SP and BKN, which are native peptldes of the coronary endothehum, and are 40-to lOO-old more potent than adenosme m triggering endothehum-dependent dllatlon m small coronary arteries 532')~34,154344 Recent studies suggest that release of BKN contributes to the resting level of coronary blood flow m human hearts and partially mediates flow-dependent dllatlon m response to Increased myocardlal demand m control subjects "' Substance P also 1s postulated to contribute to the regulation of coronary blood flow by establishing an endothehum-dependent dilator mfluence,5345 and concentrations of SP m the fentomolar range may elicit profound dilation 45 Hence, lmpaired dilator responses to BKN and SP durmg hypertension, as observed m Lhe coronary mlcrovessels of Dahl-HT rats m this study, would be postulated to ehmmate a potentially Important dilator Influence from the coronary vasculature and thereby favor constrlctlon of the coronary mlcroclrculatlon Recent reports that hypertensive patients with anglographltally normal epicardial coronary artenec show a loss of dilation to SP, as well as a bluntmg of flow-dependent, endothehummediated dilation, raise the poyslblhty that endothehal dysfunction at the coronary mlcrovascular level may faclhtate myocardlal lschemla m patients with hypertension 'J Designing therapies to restore endothehum-dependent dilation to the coronary mlcroclrculatlon during hypertension will require details about the normal endothelmm-dependent pathway for dilation m these small vessels, and such therapies will benefit from mformatlon on the mteractlon of these pathways with other mechanisms that regulate arterial tone microvasculature
